ReviewCancers2022

Oncologic Benefits of Neoadjuvant Treatment versus Upfront Surgery in Borderline Resectable Pancreatic Cancer: A Systematic Review and Meta-Analysis.

Hye-Sol Jung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.